Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

9.89
Delayed Data
As of 3:59pm ET
 +0.01 / +0.10%
Today’s Change
5.90
Today|||52-Week Range
13.18
-5.45%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close9.88
Today’s open9.83
Day’s range9.75 - 9.97
Volume255,995
Average volume (3 months)326,201
Market cap$391.5M
Dividend yield--
Data as of 3:59pm ET, 07/26/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-54.98%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book5.70

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...+0.24+1.49%
NUTRNutraceutical Intern...+0.09+0.37%
NATRNatures Sunshine Pro...-0.24-2.05%
LFVNLifeVantage Corp-0.11-0.75%
Data as of 3:59pm ET, 07/26/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs